InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:InKemia IUCT Group SA (IKM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9437
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InKemia IUCT Group SA (InKemia IUCT), formerly Institut Univ De Ciencia i Technology SA, is a biotechnology company. The company provides research and development, technological, and consulting services. It offers customized research services. InKemia IUCT provides technology services such as physical-chemical analysis and microbiology control services, quality consulting, scientific and technical consultancy, occupational safety and health/environment, and legal auditing services for occupational risk prevention. The company’s technology services also include contract pharmaceutical manufacturing services comprising manufacturing and control services for pharmaceutical products; and active pharmaceutical ingredients production services. The company serves chemical, pharmaceutical, biotechnology, cosmetic, and food and related industries. It operates offices in Mollet del Valles, Tres Cantos and Vilanova i la Geltru, Spain. InKemia IUCT is headquartered in Mollet del Valles, Spain.

InKemia IUCT Group SA (IKM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InKemia IUCT Group SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InKemia IUCT Group SA, Medical Devices Deals, 2012 to YTD 2018 9
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Myogem Health Company May Raise up to USD0.57 Million in Venture Financing 11
Partnerships 12
1nkemia IUCT Forms Joint Venture with Bionos Biotech 12
Equity Offering 13
1nkemia IUCT to Raise USD2.5 Million in Public Offering of Shares 13
InKemia IUCT Completes IPO 14
Acquisition 15
IUCT Empren Sells BioDan Sciences for USD0.2 Million 15
InKemia IUCT Group SA – Key Competitors 16
InKemia IUCT Group SA – Key Employees 17
InKemia IUCT Group SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InKemia IUCT Group SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InKemia IUCT Group SA, Deals By Therapy Area, 2012 to YTD 2018 8
InKemia IUCT Group SA, Medical Devices Deals, 2012 to YTD 2018 9
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Myogem Health Company May Raise up to USD0.57 Million in Venture Financing 11
1nkemia IUCT Forms Joint Venture with Bionos Biotech 12
1nkemia IUCT to Raise USD2.5 Million in Public Offering of Shares 13
InKemia IUCT Completes IPO 14
IUCT Empren Sells BioDan Sciences for USD0.2 Million 15
InKemia IUCT Group SA, Key Competitors 16
InKemia IUCT Group SA, Key Employees 17
InKemia IUCT Group SA, Other Locations 18
InKemia IUCT Group SA, Subsidiaries 18

List of Figures
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
InKemia IUCT Group SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
InKemia IUCT Group SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[InKemia IUCT Group SA (IKM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Public Broadcasting Service:企業の戦略・SWOT・財務情報
    Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report Summary Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Norish plc:企業の戦略・SWOT・財務情報
    Norish plc - Strategy, SWOT and Corporate Finance Report Summary Norish plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Pick N Pay Stores Limited
    Pick N Pay Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Pick N Pay Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Odfjell SE (ODF):石油・ガス:M&Aディール及び事業提携情報
    Summary Odfjell SE (Odfjell) is a shipping company that provides transportation and carrier services for various minerals and oils. The company transports organic and inorganic chemicals, petroleum products, lubricating oils, edible oils, acids, animal fats and portable alcohols. Odfjell owns and op …
  • Tri-State Generation and Transmission Association Inc:企業の戦略的SWOT分析
    Tri-State Generation and Transmission Association Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key com …
  • Northern Oil & Gas Inc (NOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Northern Oil & Gas Inc (Northern) is an oil and gas company that offers acquisition, exploration and production services. The company acquires and maintains oil and natural gas properties in Bakken and Three Forks formations within the Williston Basin in North Dakota and Montana. It offers s …
  • Revance Therapeutics Inc (RVNC)-製薬・医療分野:企業M&A・提携分析
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • Murad LLC:企業の戦略・SWOT・財務分析
    Murad LLC - Strategy, SWOT and Corporate Finance Report Summary Murad LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Vistra Energy Corp (VST):電力:M&Aディール及び事業提携情報
    Summary Vistra Energy Corp (Vistra Energy) is an investment holding company engaged in operation of integrated power business. The company through its subsidiaries is involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, and retail sales of e …
  • Genfit SA (GNFT):医療機器:M&Aディール及び事業提携情報
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program …
  • Allscripts Healthcare Solutions, Inc.:企業のM&A・事業提携・投資動向
    Allscripts Healthcare Solutions, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allscripts Healthcare Solutions, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • LifeScan Inc:企業の戦略的SWOT分析
    LifeScan Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Student Transportation Inc.:企業の戦略・SWOT・財務情報
    Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report Summary Student Transportation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Confo Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary Confo Therapeutics is a drug discovery company that conducts research and development of g protein coupled receptors targeted therapeutics. The company offers CONFO body technology. Its technology uses confobody stabilized functional conformations of g protein coupled receptors. Confo Therap …
  • The Saudi Arabian Monetary Agency:企業の戦略的SWOT分析
    The Saudi Arabian Monetary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Industrial Bank Co., Ltd.:企業の戦略・SWOT・財務情報
    Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Dana Inc:企業の戦略・SWOT・財務情報
    Dana Inc - Strategy, SWOT and Corporate Finance Report Summary Dana Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Global Clean Energy Holdings Inc:企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • ElectraNet Pty Ltd:企業の戦略的SWOT分析
    ElectraNet Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Brown Advisory Inc:企業の戦略・SWOT・財務分析
    Brown Advisory Inc - Strategy, SWOT and Corporate Finance Report Summary Brown Advisory Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆